Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Blood

• Publication date

  2000-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD.V96.7.2451.H8002451_2451_2459PMID 11001897
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Platelets augment granulocyte aggregation and cytotoxicity: uncovering of their effects by improved cell separation techniques using Percoll gradients.

  2009cited by this paper
• SICKLE CELL CRISIS

  2006cited by this paper
• Comparison of Tissue Factor Pathway in Human Umbilical Vein and Adult Saphenous Vein Endothelial Cells: Implications for Newborn Hemostasis and for Laboratory Models of Endothelial Cell Function

  1999cited by this paper
• Platelet activation in patients with sickle cell disease

  1998cited by this paper
• Interaction of sickle erythrocytes with endothelial cells in the presence of endothelial cell conditioned medium induces oxidant stress leading to transendothelial migration of monocytes.

  1998cited by this paper
• Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease.

  1998cited by this paper
• The role of the tissue factor pathway in initiation of coagulation.

  1998cited by this paper
• Tissue factor expression by endothelial cells in sickle cell anemia.

  1998cited by this paper
• Tumor necrosis factor alpha in children with sickle cell disease in stable condition.

  1997cited by this paper
• A novel technique for culture of human dermal microvascular endothelial cells under either serum-free or serum-supplemented conditions: isolation by panning and stimulation with vascular endothelial growth factor.

  1997cited by this paper
• Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity.

  1997cited by this paper
• Effect of Human Recombinant Interleukin-6 and Interleukin-8 on Monocyte Procoagulant Activity

  1997cited by this paper
• The endothelial biology of sickle cell disease.

  1997cited by this paper
• Circulating activated endothelial cells in sickle cell anemia.

  1997cited by this paper
• A quick, easy and inexpensive method for the isolation of human peripheral blood monocytes.

  1997cited by this paper
• Hydroxyurea and Sickle Cell Anemia Clinical Utility of a Myelosuppressive “Switching” Agent

  1996cited by this paper
• Altered expression of CD11b/CD18 and CD62L on human monocytes after cell preparation procedures.

  1995cited by this paper
• Transcriptional regulation of endothelial cell adhesion molecules: NF‐κB and cytokine‐inducible enhancers

  1995cited by this paper
• Leukocyte-endothelial adhesion molecules.

  1994cited by this paper
• Monitoring the acute phase response to vaso-occlusive crisis in sickle cell disease.

  1994cited by this paper
• Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm.

  1994cited by this paper
• High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease.

  1994cited by this paper
• Circulating cytokines in sickle cell patients during steady state

  1994cited by this paper
• Levels of Tumor Necrosis Factor α/Cachectin (TNFα) in Sera from Patients with Sickle Cell Disease

  1993cited by this paper
• Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion.

  1993cited by this paper
• Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage.

  1993cited by this paper
• Is there an acute-phase response in steady-state sickle cell disease?

  1993cited by this paper
• Levels of tumor necrosis factor alpha/cachectin (TNF alpha) in sera from patients with sickle cell disease.

  1993cited by this paper
• Acute phase reactants and severity of homozygous sickle cell disease

  1993cited by this paper
• Elevated immunoreactive tumor necrosis factor and interleukin-1 in sickle cell disease.

  1992cited by this paper
• Function of lipopolysaccharide (LPS)-binding protein (LBP) and CD14, the receptor for LPS/LBP complexes: a short review.

  1992cited by this paper
• Intramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-κB subunit

  1992cited by this paper
• I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention.

  1992cited by this paper
• Intramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-kappa B subunit.

  1992cited by this paper
• Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites

  1991cited by this paper
• A study of beta-thromboglobulin and platelet factor-4 plasma levels in steady state sickle cell patients.

  1990cited by this paper
• CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein.

  1990cited by this paper
• ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18)

  1990cited by this paper
• Glycoprotein IV mediates thrombospondin-dependent platelet-monocyte and platelet-U937 cell adhesion.

  1989cited by this paper
• Protein measurement using bicinchoninic acid: elimination of interfering substances.

  1989cited by this paper
• Differential Induction of Membrane‐Associated Interleukin 1 (IL‐1) Expression and IL‐1α and IL‐1β Secretion by Lipopolysaccharide and Silica in Human Monocytes

  1988cited by this paper
• Plasma membrane-associated tumor necrosis factor. A non-integral membrane protein possibly bound to its own receptor.

  1988cited by this paper
• Differential induction of membrane-associated interleukin 1 (IL-1) expression and IL-1 alpha and IL-1 beta secretion by lipopolysaccharide and silica in human monocytes.

  1988cited by this paper
• Red cell vesiculation--a common membrane physiologic event.

  1986cited by this paper
• Sickle cell anemia and central nervous system infarction: A neuropathological study

  1986cited by this paper
• Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease.

  1984cited by this paper
• Monocyte functions in sickle cell disorders.

  1983cited by this paper
• Platelet activation during steady state sickle cell disease.

  1983cited by this paper
• Hypertension and hyperparathyroidism: Inverse relation of serum phosphate level and blood pressure

  1983cited by this paper
• Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

  1983cited by this paper
• Endothelial cell and vascular damage in the sickle cell disorders.

  1982cited by this paper
• Single-step separation of red blood cells. Granulocytes and mononuclear leukocytes on discontinuous density gradients of Ficoll-Hypaque.

  1974cited by this paper
• Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

  1973cited by this paper
• Occlusion of large cerebral vessels in sickle-cell anemia.

  1972cited by this paper

• Unravelling the Immunological Enigma of Sickle Cell Disease: Current Understanding and Future Directions

  2025cites this paper
• Transcriptomic atlas reveals organ-specific disease tolerance in sickle cell mice

  2025cites this paper
• The Impact of Sleep on Neurologic and Neurocognitive Complications in Children With Sickle Cell Disease: A Scoping Review

  2025cites this paper
• Altered nasal and oral microbiomes define pediatric sickle cell disease

  2025cites this paper
• A retrospective study on sickle cell disease-associated cardiovascular anomalies

  2025cites this paper
• IFN-I-Mediated Transcriptional Reprogramming Drives Myeloid-skewed Hematopoiesis in Sickle Cell Anemia

  2025cites this paper
• Arterial Calcification as a Pseudoxanthoma Elasticum-like Manifestation in Beta-Thalassemia: Molecular Mechanisms and Significance

  2025cites this paper
• Plasma oxylipins in children with sickle cell disease: Associations with biomarkers of inflammation and endothelial activation.

  2025cites this paper
• Zinc level and its impact on the phenotype of sickle cell disease

  2025cites this paper
• Sickle Cell Anemia Screening in Newborns and Analysis of Haplotypes in Patients from Santiago Island, Cape Verde

  2024cites this paper
• Multiparametric Cardiac Magnetic Resonance Assessment in Sickle Beta Thalassemia

  2024cites this paper
• Characterizing the Immature Immunophenotype of Sickle Cell Disease Monocytes

  2024influential citation
• Physiopathologie de la drépanocytose et perspectives thérapeutiques

  2024cites this paper
• Trained immunity causes myeloid cell hypercoagulability

  2024cites this paper
• The APC-EPCR-PAR1 axis in sickle cell disease

  2023cites this paper
• The inflammatory profiles of pulmonary alveolar macrophages and alveolar type 2 cells in SCD

  2023cites this paper
• Prevalence and outcomes of pulmonary embolism with sickle cell disease: Analysis of the Nationwide Inpatient Sample, 2016–2020

  2023cites this paper
• Intestinal barrier functions in hematologic and oncologic diseases

  2023cites this paper
• Hemolysis dictates monocyte differentiation via two distinct pathways in sickle cell disease vaso-occlusion

  2023cites this paper
• Blockade of endothelin-1 receptor B regulates molecules of the major histocompatibility complex in sickle cell disease

  2023cites this paper
• Predisposing Factors and Incidence of Venous Thromboembolism among Hospitalized Patients with Sickle Cell Disease

  2023cites this paper
• Inflammatory status in pediatric sickle cell disease: Unravelling the role of immune cell subsets

  2023cites this paper
• Acute chest syndrome, airway inflammation and lung function in sickle cell disease

  2023cites this paper
• The Role of Inflammation in The Cellular and Molecular Mechanisms of Cardiopulmonary Complications of Sickle Cell Disease

  2023cites this paper
• Isoquercetin for thromboinflammation in sickle cell disease: a randomized double-blind placebo-controlled trial

  2023cites this paper
• Impact of Abnormal Leukocyte Count in the Pathophysiology of Sickle Cell Anemia

  2022cites this paper
• Recruitment of α4β7 monocytes and neutrophils to the brain in experimental colitis is associated with elevated cytokines and anxiety-like behavior

  2022cites this paper
• Sickle cell inflammation: is HbS the answer?

  2022cites this paper
• Emerging functional microfluidic assays for the study of thromboinflammation in sickle cell disease

  2022cites this paper
• Contribution of ADAMTS13‐independent VWF regulation in sickle cell disease

  2022cites this paper
• Associations between alloantibodies and multiple red blood cell transfusions in patients with sickle cell anemia

  2022cites this paper
• Evaluation of Beta-2 Integrin and Platelets Roles in Sickle Cell Disease Pathogenicity in Basrah Governorate Patients

  2022cites this paper
• Targeting the Hematopoietic Stem Cell Niche in β-Thalassemia and Sickle Cell Disease

  2022cites this paper
• Monocyte HLA-DR Expression to Monitor Immune Response and Potential Infection Risks Following Vaso-Occlusive Crises in Patients with Sickle Cell Anemia

  2022cites this paper
• The NLRP3 inflammasome fires up heme-induced inflammation in hemolytic conditions.

  2022cites this paper
• Assessment of humoral immunity and nutritionally essential trace elements in steady-state sickle cell disease Nigerian children before and after Prevenar 13 pneumococcal vaccination

  2022cites this paper
• Endothelial TLR4 Expression Mediates Vaso-Occlusive Crisis in Sickle Cell Disease

  2021cites this paper
• Leukocyte - Cerebral Endothelial Cell Interactions in the Brain Lead to Anxiety-like Behaviour in Experimental Colitis

  2021cites this paper
• Inflammatory Dendritic Cells Contribute to Regulate the Immune Response in Sickle Cell Disease

  2021cites this paper
• Sulfated non-anticoagulant heparin derivative modifies intracellular hemoglobin, inhibits cell sickling in vitro, and prolongs survival of sickle cell mice under hypoxia

  2021cites this paper
• Intestinal pathophysiological abnormalities in steady state and after vaso‐occlusive crisis in murine sickle cell disease

  2021cites this paper
• Genetic contribution and functional impairment of inflammasome in sickle cell disease.

  2021cites this paper
• The Role of RBC Oxidative Stress in Sickle Cell Disease: From the Molecular Basis to Pathologic Implications

  2021cites this paper
• Agonistic Anti-CD40 Antibody Triggers an Acute Liver Crisis With Systemic Inflammation in Humanized Sickle Cell Disease Mice

  2021cites this paper
• Vaso-occlusive crisis in sickle cell disease: a vicious cycle of secondary events

  2021cites this paper
• Cardiac Manifestations in Adult Sickle Cell Disease Patients at a Tertiary Care Hospital in Chhattisgarh, India

  2021cites this paper
• Extracellular Vesicles in Sickle Cell Disease: Plasma Concentration, Blood Cell Types Origin Distribution and Biological Properties

  2021cites this paper
• Haematological abnormalities in children with sickle cell disease and non-severe malaria infection in western Kenya

  2021cites this paper
• Vasculo‐toxic and pro‐inflammatory action of unbound haemoglobin, haem and iron in transfusion‐dependent patients with haemolytic anaemias

  2021cites this paper
• AN OVERVIEW OF SICKLE CELL DISEASE VASO-OCCLUSIVE CRISIS AND APPROACHES TO MANAGEMENT

  2021cites this paper
• Plasma Concentration of 12-Hydroxyeicosatetraenoic Acid, Single Nucleotide Polymorphisms of 12-Lipooxygenase Gene and Vaso-Occlusion in Sickle Cell Disease

  2021cites this paper
• Cardiac pathophysiology in sickle cell disease

  2021cites this paper
• Type I interferon is induced by hemolysis and drives antibody-mediated erythrophagocytosis in sickle cell disease.

  2021cites this paper
• Sickle Cell Anemia Mediates Carotid Artery Expansive Remodeling That Can Be Prevented by Inhibition of JNK (c-Jun N-Terminal Kinase)

  2020cites this paper
• The molecular basis for the prothrombotic state in sickle cell disease.

  2020cites this paper
• LSHTM Research Online

  2020cites this paper
• The molecular basis for the prothrombotic state in sickle cell disease.

  2020cites this paper
• The multifaceted role of ischemia/reperfusion in sickle cell anemia.

  2020cites this paper
• Nrf2 deficiency in mice attenuates erythropoietic stress-related macrophage hypercellularity.

  2020cites this paper
• Mitochondrial Reactive Oxygen Species Participate in Signaling Triggered by Heme in Macrophages and upon Hemolysis

  2020cites this paper
• Association between haematological parameters and sickle cell genotypes in children with Plasmodium falciparum malaria resident in Kisumu County in Western Kenya

  2020cites this paper
• The Red Blood Cell—Inflammation Vicious Circle in Sickle Cell Disease

  2020cites this paper
• The multifaceted role of ischemia/reperfusion in sickle cell anemia

  2020cites this paper
• Convergence of Inflammatory Pathways in Allergic Asthma and Sickle Cell Disease

  2020cites this paper
• Innate immune cells, major protagonists of sickle cell disease pathophysiology

  2020cites this paper
• Noncanonical Roles of Caspase-4 and Caspase-5 in Heme-Driven IL-1β Release and Cell Death

  2020cites this paper
• Pathologic angiogenesis in the bone marrow of humanized sickle cell mice is reversible by blood transfusion.

  2020cites this paper
• Impact of activated monocyte and endothelial dysfunction on coagulopathy in Egyptian adult beta thalassemic patients

  2020cites this paper
• Innovations in Targeted Anti‐Adhesion Treatment for Sickle Cell Disease

  2020cites this paper
• Cardiovascular Sequelae of Sickle Cell Disease.

  2020cites this paper
• Life-Threatening Infectious Complications in Sickle Cell Disease: A Concise Narrative Review

  2020cites this paper
• Inhaled steroids associated with decreased macrophage markers in nonasthmatic individuals with sickle cell disease in a randomized trial

  2019cites this paper
• Distribution of Haemoglobin phenotype and haemoglobin concentration among children and adults in sickle cell disease patients in Portharcourt Rivers state, Nigeria

  2019cites this paper
• Bone marrow characterization in sickle cell disease: inflammation and stress erythropoiesis lead to suboptimal CD34 recovery

  2019cites this paper
• Sickle cell disease: Hemostatic and inflammatory changes, and their interrelation.

  2019cites this paper
• Characterization of natural killer cells expressing markers associated with maturity and cytotoxicity in children and young adults with sickle cell disease

  2019cites this paper
• Risk of severe dengue is higher in patients with sickle cell disease: a scoping review.

  2019cites this paper
• Airway Inflammation and Lung Function in Sickle Cell Disease

  2019cites this paper
• Mechanisms of haemolysis-induced kidney injury

  2019cites this paper
• Hydroxyurea alters circulating monocyte subsets and dampens its inflammatory potential in sickle cell anemia patients

  2019cites this paper
• Correlation of NLR with Oxidative Stress Markers in Sickle Cell Anemia with Vasoocclusive Crisis

  2019cites this paper
• Research Journal of Applied Biotechnology (RJAB)

  2019cites this paper
• A novel, highly potent and selective phosphodiesterase-9 inhibitor for the treatment of sickle cell disease

  2019cites this paper
• Red blood cell alloimmunization is associated with lower expression of FcγR1 on monocyte subsets in patients with sickle cell disease

  2019cites this paper
• Immunogenetics in sickle cell disease

  2019cites this paper
• TTP-like syndrome associated with hemoglobin SC disease treated successfully with plasma and red cell exchange

  2019cites this paper
• Airway inflammation in sickle cell disease—A translational perspective

  2018cites this paper
• RON kinase inhibition reduces renal endothelial injury in sickle cell disease mice

  2018cites this paper
• Haemolytic anaemia in Kavaratti island, Lakshadweep: A hospital based study.

  2018cites this paper
• Shear dependent red blood cell adhesion in microscale flow.

  2018cites this paper
• Hyperhemolysis Syndrome in Patients With Sickle Cell Disease.

  2018cites this paper
• ASSESSMENT OF VITAMIN D LEVELS IN SUDANESE PATIENTS WITH SICKLE CELL DISEASE AND ITS IMPACT ON SICKLE CELLS COMPLICATIONS- KHATOUM-2017

  2018cites this paper
• HbS results from a point mutation in the gene for the beta-globin chain of adult hemoglobin. In the deoxygenated form of HbS, the beta-6 valine becomes buried in a hydrophobic pocket on an adjacent beta-globin chain, joining the molecules

  2018cites this paper
• Impact of aerobic exercises on selected inflammatory markers and immune system response among patients with sickle cell anemia in asymptomatic steady state

  2018cites this paper
• Intravascular hemolysis activates complement via cell-free heme and heme-loaded microvesicles.

  2018cites this paper
• Inflammation in sickle cell disease

  2018cites this paper
• Identification of therapeutic targets for inflammation in sickle cell disease (SCD) among Indian patients using gene expression data analysis

  2018cites this paper
• Nitric Oxide for Inhalation in the Acute Treatment of Sickle Cell Pain Crisis

  2017cites this paper
• Placenta growth factor mediated gene regulation in sickle cell disease.

  2017cites this paper
• Developing new pharmacotherapeutic approaches to treating sickle‐cell disease

  2017cites this paper